SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-19-002974
Filing Date
2019-12-12
Accepted
2019-12-12 17:04:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d09488034_12122019.htm SC 13D 220307
2 JOINT FILING AGREEMENT ex991to13d09488034_12122019.htm EX-99.1 15109
  Complete submission text file 0000921895-19-002974.txt   237308
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87950 | Film No.: 191282513
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018
Business Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018 (212) 321-0048
ENGINE CAPITAL, L.P. (Filed by) CIK: 0001580320 (see all company filings)

IRS No.: 364755478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D